Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Liver X Receptors Regulate Cholesterol Metabolism and Immunity in Hepatic Nonparenchymal Cells.

Endo-Umeda K, Makishima M.

Int J Mol Sci. 2019 Oct 11;20(20). pii: E5045. doi: 10.3390/ijms20205045. Review.

2.

Competitive Binding Assay with an Umbelliferone-Based Fluorescent Rexinoid for Retinoid X Receptor Ligand Screening.

Yamada S, Kawasaki M, Fujihara M, Watanabe M, Takamura Y, Takioku M, Nishioka H, Takeuchi Y, Makishima M, Motoyama T, Ito S, Tokiwa H, Nakano S, Kakuta H.

J Med Chem. 2019 Oct 10;62(19):8809-8818. doi: 10.1021/acs.jmedchem.9b00995. Epub 2019 Sep 18.

PMID:
31483660
3.

Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.

Ando K, Nakamura Y, Nagase H, Nakagawara A, Koshinaga T, Wada S, Makishima M.

Int J Mol Sci. 2019 Jul 29;20(15). pii: E3700. doi: 10.3390/ijms20153700.

4.

Response to: Is vancomycin clearance really correlated with hemoglobin? Arguments that it's not.

Chuma M, Makishima M.

Eur J Clin Pharmacol. 2019 Jul 24. doi: 10.1007/s00228-019-02728-8. [Epub ahead of print] No abstract available.

PMID:
31342105
5.

Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab.

Maekawa T, Kato S, Kawamura T, Takada K, Sone T, Ogata H, Saito K, Izumi T, Nagao S, Takano K, Okada Y, Tachi N, Teramoto M, Horiuchi T, Hikota-Saga R, Endo-Umeda K, Uno S, Osawa Y, Kobayashi A, Kobayashi S, Sato K, Hashimoto M, Suzu S, Usuki K, Morishita S, Araki M, Makishima M, Komatsu N, Kimura F.

Blood. 2019 Sep 5;134(10):814-825. doi: 10.1182/blood.2019000051. Epub 2019 Jul 3.

PMID:
31270105
6.

[A Case of an Elderly Individual with Breast Cancer Diagnosed as Paget's Disease after Mastectomy].

Kubota H, Suzuki Y, Adachi K, Suzuki S, Hara Y, Fujisaki S, Makishima M, Saga R, Hirano T, Sakurai K.

Gan To Kagaku Ryoho. 2019 Apr;46(4):814-816. Japanese.

PMID:
31164545
7.

[Usefulness of Breast Ultrasound in Follow-Up of Post-Operative Metachronous Contralateral Breast Cancer-A Case Report].

Suzuki Y, Sakurai K, Adachi K, Kubota H, Suzuki S, Takei S, Hara Y, Enomoto K, Hirano T, Makishima M.

Gan To Kagaku Ryoho. 2019 Apr;46(4):781-783. Japanese.

PMID:
31164534
8.

[Usefulness of Automated Breast Ultrasound for Deciding on a Surgical Approach in a Patient with Breast Cancer- A Case Report].

Suzuki Y, Sakurai K, Adachi K, Kubota H, Suzuki S, Takei S, Hara Y, Enomoto K, Hirano T, Makishima M.

Gan To Kagaku Ryoho. 2019 Apr;46(4):778-780. Japanese.

PMID:
31164533
9.

Diallyl Trisulfide Enhances Benzo[a]pyrene-induced CYP1A1 Expression and Metabolic Activation in Hepatic HepG2 Cells.

Uno S, Sakai M, Fujinari Y, Hosono T, Seki T, Makishima M.

Anticancer Res. 2019 May;39(5):2369-2375. doi: 10.21873/anticanres.13354.

PMID:
31092429
10.

Frontline Science: Concanavalin A-induced acute hepatitis is attenuated in vitamin D receptor knockout mice with decreased immune cell function.

Umeda N, Endo-Umeda K, Nakashima H, Kato S, Seki S, Makishima M.

J Leukoc Biol. 2019 Oct;106(4):791-801. doi: 10.1002/JLB.3HI0219-048R. Epub 2019 Apr 29.

PMID:
31034649
11.

Application of a Waveguide-Mode Sensor to Blood Testing for Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus and Treponema pallidum Infection.

Uno S, Shimizu T, Tanaka T, Ashiba H, Fujimaki M, Tanaka M, Awazu K, Makishima M.

Sensors (Basel). 2019 Apr 11;19(7). pii: E1729. doi: 10.3390/s19071729.

12.

Flavonoids differentially modulate liver X receptors activity-Structure-function relationship analysis.

Fouache A, Zabaiou N, De Joussineau C, Morel L, Silvente-Poirot S, Namsi A, Lizard G, Poirot M, Makishima M, Baron S, Lobaccaro JA, Trousson A.

J Steroid Biochem Mol Biol. 2019 Jun;190:173-182. doi: 10.1016/j.jsbmb.2019.03.028. Epub 2019 Apr 5.

PMID:
30959154
13.

Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeleton.

Nanjyo S, Ohgane K, Yoshioka H, Makishima M, Hashimoto Y, Noguchi-Yachide T.

Bioorg Med Chem. 2019 May 15;27(10):1952-1961. doi: 10.1016/j.bmc.2019.03.042. Epub 2019 Mar 26.

PMID:
30940565
14.

[A Case of Duplicated Cancer Simultaneously Causing Breast and Endometrial Cancer].

Kubota H, Suzuki Y, Adachi K, Suzuki S, Hara Y, Fujisaki S, Makishima M, Saga R, Hirano T, Sakurai K.

Gan To Kagaku Ryoho. 2019 Feb;46(2):339-341. Japanese.

PMID:
30914553
15.

[Advanced-Stage Breast Cancer Discovered by Cervical Lymphadenopathy in an Elderly Patient-Report of a Case].

Adachi K, Sakurai K, Kubota H, Suzuki Y, Suzuki S, Makishima M, Koshinaga T.

Gan To Kagaku Ryoho. 2019 Feb;46(2):312-314. Japanese.

PMID:
30914544
16.

[Treatment for Breast Cancer in an Elderly Male Patient-Report of a Case].

Adachi K, Sakurai K, Kubota H, Suzuki Y, Suzuki S, Makishima M, Koshinaga T.

Gan To Kagaku Ryoho. 2019 Feb;46(2):309-311. Japanese.

PMID:
30914543
17.

Relationship between hemoglobin levels and vancomycin clearance in patients with sepsis.

Chuma M, Makishima M, Imai T, Tochikura N, Suzuki S, Kuwana T, Sawada N, Iwabuchi S, Sekimoto M, Nakayama T, Sakaue T, Kikuchi N, Yoshida Y, Kinoshita K.

Eur J Clin Pharmacol. 2019 Jul;75(7):929-937. doi: 10.1007/s00228-019-02661-w. Epub 2019 Mar 14.

PMID:
30868193
18.

Caution for simple sequence repeat number variation in the mitochondrial DNA D-loop to determine cancer-specific variants.

Nakai T, Sakurada A, Endo T, Kobayashi H, Masuda S, Makishima M, Esumi M.

Oncol Lett. 2019 Feb;17(2):1883-1888. doi: 10.3892/ol.2018.9809. Epub 2018 Dec 7.

19.

A partial agonist for retinoid X receptor mitigates experimental colitis.

Onuki M, Watanabe M, Ishihara N, Suzuki K, Takizawa K, Hirota M, Yamada T, Egawa A, Shibahara O, Nishii M, Fujihara M, Makishima M, Takahashi D, Furusawa Y, Kakuta H, Hase K.

Int Immunol. 2019 Mar 28;31(4):251-262. doi: 10.1093/intimm/dxy089.

PMID:
30590577
20.

[Breast Cancer Operation for a Patient Administered Immunosuppressive Drug-A Case Report].

Adachi K, Sakurai K, Kubota H, Suzuki Y, Suzuki S, Makishima M, Koshinaga T.

Gan To Kagaku Ryoho. 2018 Oct;45(10):1501-1503. Japanese.

PMID:
30382058
21.

[Treatment Experience of Palbociclib as a New Checkpoint Inhibitor].

Sakurai K, Fujisaki S, Kubota H, Suzuki Y, Hara Y, Suzuki S, Adachi K, Tomita R, Enomoto K, Hirano T, Saga R, Makishima M.

Gan To Kagaku Ryoho. 2018 Oct;45(10):1498-1500. Japanese.

PMID:
30382057
22.

[Indoleamine 2,3-Dioxygenase Activity during Long-Term Letrozole Therapy for Hormone Receptor-Positive Breast Cancer].

Suzuki Y, Sakurai K, Adachi K, Kubota H, Suzuki S, Takei S, Hara Y, Enomoto K, Hirano T, Makishima M.

Gan To Kagaku Ryoho. 2018 Oct;45(10):1495-1497. Japanese.

PMID:
30382056
23.

[Bone and calcium metabolism associated with malignancy. Vitamin D and cancer.]

Makishima M.

Clin Calcium. 2018;28(11):1465-1472. doi: CliCa181114651472. Japanese.

PMID:
30374002
24.

[Rickets/Osteomalacia. The function and mechanism of vitamin D action.]

Makishima M.

Clin Calcium. 2018;28(10):1319-1326. doi: CliCa181013191326. Japanese.

PMID:
30269113
25.

Deletion of Bmal1 Prevents Diet-Induced Ectopic Fat Accumulation by Controlling Oxidative Capacity in the Skeletal Muscle.

Wada T, Ichihashi Y, Suzuki E, Kosuge Y, Ishige K, Uchiyama T, Makishima M, Nakao R, Oishi K, Shimba S.

Int J Mol Sci. 2018 Sep 18;19(9). pii: E2813. doi: 10.3390/ijms19092813.

26.

Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton.

Nishiyama Y, Mori S, Makishima M, Fujii S, Kagechika H, Hashimoto Y, Ishikawa M.

ACS Med Chem Lett. 2018 Jun 23;9(7):641-645. doi: 10.1021/acsmedchemlett.8b00058. eCollection 2018 Jul 12.

27.

Efficient Lead Finding, Activity Enhancement and Preliminary Selectivity Control of Nuclear Receptor Ligands Bearing a Phenanthridinone Skeleton.

Nishiyama Y, Fujii S, Makishima M, Hashimoto Y, Ishikawa M.

Int J Mol Sci. 2018 Jul 18;19(7). pii: E2090. doi: 10.3390/ijms19072090.

28.

25 S-Adamantyl-23-yne-26,27-dinor-1α,25-dihydroxyvitamin D3: Synthesis, Tissue Selective Biological Activities, and X-ray Crystal Structural Analysis of Its Vitamin D Receptor Complex.

Otero R, Ishizawa M, Numoto N, Ikura T, Ito N, Tokiwa H, Mouriño A, Makishima M, Yamada S.

J Med Chem. 2018 Aug 9;61(15):6658-6673. doi: 10.1021/acs.jmedchem.8b00427. Epub 2018 Jul 23.

PMID:
29989817
29.

Lithocholic Acid Is a Vitamin D Receptor Ligand That Acts Preferentially in the Ileum.

Ishizawa M, Akagi D, Makishima M.

Int J Mol Sci. 2018 Jul 6;19(7). pii: E1975. doi: 10.3390/ijms19071975.

30.

Farnesoid X Receptor Activation Enhances Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.

Kainuma M, Takada I, Makishima M, Sano K.

Int J Mol Sci. 2018 Jun 28;19(7). pii: E1898. doi: 10.3390/ijms19071898.

31.

Liver X receptors regulate hepatic F4/80 + CD11b+ Kupffer cells/macrophages and innate immune responses in mice.

Endo-Umeda K, Nakashima H, Komine-Aizawa S, Umeda N, Seki S, Makishima M.

Sci Rep. 2018 Jun 18;8(1):9281. doi: 10.1038/s41598-018-27615-7.

32.

Combined treatment with benzo[a]pyrene and 1α,25-dihydroxyvitamin D3 induces expression of plasminogen activator inhibitor 1 in monocyte/macrophage-derived cells.

Nakagawa M, Uno S, Iriyama N, Matsunawa M, Makishima M, Takeuchi J, Tsuboi I, Hatta Y, Takei M.

Toxicol Appl Pharmacol. 2018 Apr 15;345:48-56. doi: 10.1016/j.taap.2018.03.003. Epub 2018 Mar 7.

PMID:
29524502
33.

Sensitive typing of reverse ABO blood groups with a waveguide-mode sensor.

Uno S, Tanaka T, Ashiba H, Fujimaki M, Tanaka M, Hatta Y, Takei M, Awazu K, Makishima M.

J Biosci Bioeng. 2018 Jul;126(1):131-137. doi: 10.1016/j.jbiosc.2018.01.019. Epub 2018 Feb 28.

PMID:
29499994
34.

Ess2 bridges transcriptional regulators and spliceosomal complexes via distinct interacting domains.

Takada I, Tsuchiya M, Yanaka K, Hidano S, Takahashi S, Kobayashi T, Ogawa H, Nakagawa S, Makishima M.

Biochem Biophys Res Commun. 2018 Mar 4;497(2):597-604. doi: 10.1016/j.bbrc.2018.02.110. Epub 2018 Feb 16.

PMID:
29454968
35.

Dysregulation of Kupffer Cells/Macrophages and Natural Killer T Cells in Steatohepatitis in LXRα Knockout Male Mice.

Endo-Umeda K, Nakashima H, Umeda N, Seki S, Makishima M.

Endocrinology. 2018 Mar 1;159(3):1419-1432. doi: 10.1210/en.2017-03141.

PMID:
29409022
36.

Structural development of tetrachlorophthalimides as liver X receptor β (LXRβ)-selective agonists with improved aqueous solubility.

Nomura S, Endo-Umeda K, Fujii S, Makishima M, Hashimoto Y, Ishikawa M.

Bioorg Med Chem Lett. 2018 Feb 15;28(4):796-801. doi: 10.1016/j.bmcl.2017.12.024. Epub 2017 Dec 13.

PMID:
29398545
37.

[Breast Cancer Occurring in the Axillary Area - A Case Report].

Adachi K, Sakurai K, Suzuki S, Kubota H, Hara Y, Abe K, Fujiwara A, Hirano T, Enomoto K, Masuda S, Makishima M, Koshinaga T.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1635-1637. Japanese.

PMID:
29394726
38.

Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice.

Uno S, Nebert DW, Makishima M.

Food Chem Toxicol. 2018 Mar;113:73-82. doi: 10.1016/j.fct.2018.01.029. Epub 2018 Jan 31.

39.

[Long-Term Capecitabine Therapy Was Successful for Locally Advanced Breast Cancer Patient - Report of a Case].

Adachi K, Sakurai K, Suzuki S, Kubota H, Hara Y, Fujiwara A, Enomoto K, Izu A, Sugitani M, Makishima M, Koshinaga T.

Gan To Kagaku Ryoho. 2018 Jan;45(1):94-96. Japanese.

PMID:
29362319
40.

Validity and responsiveness of the work functioning impairment scale (WFun) in workers with pain due to musculoskeletal disorders.

Makishima M, Fujino Y, Kubo T, Izumi H, Uehara M, Oyama I, Matsuda S.

J Occup Health. 2018 Mar 27;60(2):156-162. doi: 10.1539/joh.17-0166-OA. Epub 2017 Dec 28.

41.

Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.

Ishibashi M, Yamaguchi H, Hirotani Y, Sakurada A, Endo T, Sugitani M, Takayama T, Makishima M, Esumi M.

Arch Virol. 2018 Apr;163(4):855-865. doi: 10.1007/s00705-017-3675-8. Epub 2017 Dec 16.

PMID:
29248968
42.

The Rosiglitazone-Like Effects of Vitexilactone, a Constituent from Vitex trifolia L. in 3T3-L1 Preadipocytes.

Nishina A, Itagaki M, Sato D, Kimura H, Hirai Y, Phay N, Makishima M.

Molecules. 2017 Nov 22;22(11). pii: E2030. doi: 10.3390/molecules22112030.

43.

Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.

Chuma M, Makishima M, Imai T, Tochikura N, Suzuki S, Kuwana T, Sawada N, Komatsu T, Sakaue T, Kikuchi N, Yoshida Y, Kinoshita K.

Ther Drug Monit. 2018 Feb;40(1):109-114. doi: 10.1097/FTD.0000000000000459.

PMID:
29095798
44.

[Update on recent progress in vitamin D research. Vitamin D receptor and the nuclear receptor superfamily.]

Makishima M.

Clin Calcium. 2017;27(11):1533-1541. doi: CliCa171115331541. Review. Japanese.

PMID:
29074825
45.

[Two Cases in Which Eribulin Mesylate Was Effective for Taxane-Resistant Advanced Breast Cancer].

Adachi K, Suzuki S, Kubota H, Hara Y, Fujiwara A, Waga E, Hirano T, Enomoto K, Sakurai K, Makishima M, Koshinaga T.

Gan To Kagaku Ryoho. 2017 Oct;44(10):938-940. Japanese.

PMID:
29066702
46.

[Clinical Evaluation of Indoleamine 2, 3-Dioxygenase in the Serum of Patients with Locally Advanced Breast Cancer during Mohs Paste Treatment].

Kubota H, Sakurai K, Fujisaki S, Hara Y, Suzuki S, Adachi K, Tomita R, Enomoto K, Hirano T, Saga R, Makishima M.

Gan To Kagaku Ryoho. 2017 Oct;44(10):915-917. Japanese.

PMID:
29066694
47.

[Clinical Evaluation of Immunosuppressive Acidic Protein in the Serum of Patients with Inflammatory Breast Recurrence].

Goto H, Sakurai K, Fujisaki S, Kubota H, Hara Y, Suzuki S, Adachi K, Tomita R, Enomoto K, Hirano T, Saga R, Makishima M.

Gan To Kagaku Ryoho. 2017 Oct;44(10):909-911. Japanese.

PMID:
29066692
48.

[Indoleamine 2,3-Dioxygenase Activity during Letrozol Therapy for an Elderly Breast Cancer Patient].

Sakurai K, Fujisaki S, Kubota H, Hara Y, Suzuki S, Adachi K, Tomita R, Enomoto K, Hirano T, Saga R, Makishima M.

Gan To Kagaku Ryoho. 2017 Oct;44(10):892-895. Japanese.

PMID:
29066687
49.

[Indoleamine 2,3-Dioxygenase Activity during Fulvestrant Therapy for Aromatase Inhibitor Resistant Metastatic Breast Cancer].

Sakurai K, Fujisaki S, Kubota H, Hara Y, Suzuki S, Adachi K, Tomita R, Enomoto K, Hirano T, Saga R, Makishima M.

Gan To Kagaku Ryoho. 2017 Oct;44(10):886-888. Japanese.

PMID:
29066685
50.

Synthesis of novel vitamin K derivatives with alkylated phenyl groups introduced at the ω-terminal side chain and evaluation of their neural differentiation activities.

Sakane R, Kimura K, Hirota Y, Ishizawa M, Takagi Y, Wada A, Kuwahara S, Makishima M, Suhara Y.

Bioorg Med Chem Lett. 2017 Nov 1;27(21):4881-4884. doi: 10.1016/j.bmcl.2017.09.038. Epub 2017 Sep 18.

Supplemental Content

Loading ...
Support Center